Safeguard Scientifics Inc (SFES)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 293,520 | 246,402 | 252,581 | 258,413 | 318,614 |
| Marketable Securities | 5,089 | 22,437 | 8,752 | 10,818 | 11,016 |
| Receivables | 135,477 | 183,764 | 125,526 | 179,668 | 169,380 |
| Inventories | 36,341 | 29,312 | 26,327 | 30,181 | 39,084 |
| TOTAL | $482,879 | $495,679 | $427,796 | $492,125 | $551,090 |
| Non-Current Assets | |||||
| PPE Net | 34,674 | 36,289 | 38,140 | 38,610 | 57,132 |
| Investments And Advances | 56,271 | 66,069 | 82,165 | 79,407 | 89,474 |
| Intangibles | 228,042 | 228,226 | 223,722 | 225,395 | 176,721 |
| Other Non-Current Assets | 23,142 | 27,753 | 29,963 | 33,129 | 45,797 |
| TOTAL | $342,129 | $358,337 | $373,990 | $376,541 | $369,124 |
| Total Assets | $825,008 | $854,016 | $801,786 | $868,666 | $920,214 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,141 | 12,357 | 12,043 | 11,517 | 11,101 |
| Accounts payable and accrued liabilities | 87,506 | 137,295 | 90,598 | 121,793 | 142,097 |
| Accrued Expenses | 97,602 | 88,361 | 94,372 | 98,377 | 110,344 |
| TOTAL | $199,249 | $238,013 | $197,013 | $249,979 | $263,542 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,771 | 1,976 | 2,221 | 1,998 | 14,162 |
| Deferred Revenues | N/A | N/A | N/A | 18,292 | N/A |
| Other Non-Current Liabilities | 351,984 | 350,160 | 345,170 | 344,416 | 340,042 |
| TOTAL | $354,755 | $352,136 | $347,391 | $346,414 | $354,204 |
| Total Liabilities | $554,004 | $590,149 | $544,404 | $596,393 | $617,746 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,893 | 19,880 | 19,889 | 19,890 | 19,907 |
| Common Shares | 11,945 | 11,945 | 11,945 | 11,945 | 11,945 |
| Retained earnings | -477,314 | -495,556 | -492,406 | -476,867 | -445,671 |
| Other shareholders' equity | -1,706 | 10,248 | -439 | -1,087 | -2,088 |
| TOTAL | $271,004 | $263,867 | $257,382 | $272,273 | $302,468 |
| Total Liabilities And Equity | $825,008 | $854,016 | $801,786 | $868,666 | $920,214 |